関連する実験動画
Updated: Mar 1, 2026

06:23
Diagnosis and Surgical Treatment of Human Brucellar Spondylodiscitis
Published on: May 23, 2021
5.5K
ブルセラ症および相対リスクのメタアナリシス
Medicine
|February 27, 2026
まとめ
動物の乳、乳製品、病気の動物の生肉、および血液の消費は、ヒトのブルセラ症の重要なリスク要因です。これらの食習慣は、この感染症に罹患する可能性を高めます。
科学分野:
- 疫学; 感染症; 公衆衛生
背景:
- ブルセラ症は、世界的な健康への影響を持つ重要な人獣共通感染症です。食事関連リスク要因を理解することは、効果的な予防および制御戦略にとって重要です。
研究 の 目的:
- ヒトのブルセラ症に関連する主な食事関連リスク要因を特定および定量化すること。公衆衛生介入のためのエビデンスに基づいた参照を提供すること。
主な方法:
- 主要なデータベース(PubMed、Web of Science、CNKI、Wanfang)を対象とした体系的な文献検索が実施されました。ヒトのブルセラ症の食事関連リスク要因に関する57件の関連研究がメタアナリシスに含まれました。メタアナリシスは、リスク要因を評価するために固定効果またはランダム効果モデルを使用したReview Manager 5.3を用いて実施されました。
主要な成果:
- 動物の乳の摂取(OR=5.12)および病気または死んだ動物の肉の摂取(OR=4.54)は、ブルセラ症と強く関連していました。乳製品の摂取(OR=2.28)および血液の摂取(OR=2.72)も重要なリスク要因として浮上しました。不十分な手指衛生および人獣共通感染症の飲料水源が特定されましたが、この特定のメタアナリシスの概要では定量化されていません。
結論:
- 動物の乳、乳製品、病気/死んだ動物の肉、および血液の消費は、ヒトのブルセラ症の主な食事関連リスク要因です。これらの発見は、ブルセラ症予防における安全な食品の取り扱いと消費習慣の重要性を強調しています。これらの食事習慣に焦点を当てたターゲットを絞った公衆衛生キャンペーンは、ブルセラ症の伝染を減らすのに役立ちます。
さらに関連する動画
15:29Microscopy-based Assays for High-throughput Screening of Host Factors Involved in Brucella Infection of Hela Cells
Published on: August 5, 2016
8.7K
12:53Collection and Processing of Lymph Nodes from Large Animals for RNA Analysis: Preparing for Lymph Node Transcriptomic Studies of Large Animal Species
Published on: May 19, 2018
28.9K
関連する概念動画
Relative Risk
2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
503
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
503
Bioavailability Study Design: Absolute Versus Relative Bioavailability
466
Bioavailability is a crucial pharmacokinetic parameter that quantifies the proportion of an administered drug that reaches the systemic circulation and is available for therapeutic action. Regulatory agencies mandate the assessment of bioavailability, typically measured as the area under the drug plasma concentration-versus-time curve (AUC), to ensure the efficacy and safety of pharmaceutical products. These evaluations are categorized as absolute and relative bioavailability studies.Absolute...
466
Odds Ratio
2.0K
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
2.0K
Bias in Epidemiological Studies
1.5K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.5K
Hazard Ratio
661
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
661